The Melanoma Hub – Home Forums Targeted therapy Dosing and administration New BRAF/MEK inhibitors coming to market Reply To: New BRAF/MEK inhibitors coming to market

#4771
Expert Nurse
Avatar photoRajni Kannan

    Has anyone heard an update on when the FDA will be approving these medications? We have a few patients whose Pyrexia on danrafenib and tramatenib is really signicant and even with various interventions we are not able to keep them consistently on drugs.